CCC Diagnostics, LLC (CCCD) was formed in 2004 by a core group of former Johns Hopkins University researchers whose distinguished careers cover 90+ years of leadership in biophysics, oncology and imaging. The company’s mission is to aid physicians in setting up a personalized treatment regimen for individual cancer patients by establishing drug response guides for selection of effective chemotherapy. CCCD is dedicated to “saving lives and life savings.”
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 04/01/07 | Seed | 0.075M | Unknown | |
| 04/01/07 | Seed | 0.075M | Unknown | |
| 04/01/07 | Seed | 0.075M | Unknown | |
| View more financial info about CCC Diagnostics | ||||
People
Paul Ts’o (Managing Director)
David Van Echo (Laboratory Director)
Stephen Lesko (Research Director)
News
Life sciences briefing: Monday, Dec. 10, 2007
December 10, 2007 5:26 pm
TODAY’S HEADLINES: Fundamental Applied Biology pulls in $21M for proteins without cells (release) Diagnostics maker Asuragen receives $19M (release) Stroke-device… Continue reading ⟩